CIGP successfully advised the shareholders of Alliance Pharma (Cambodge) on the sale of a controlling stake to Zuellig Pharma. CIGP leveraged its expertise in financial advisory, experience in the healthcare sector and its local presence in both Europe and Asia.
CIGP acted as the exclusive sell-side financial advisor to the shareholders of Alliance Pharma (Cambodge), a leading healthcare and consumer health products distributor in Cambodia, on the sale of a controlling stake to Zuellig Pharma.
Alliance Pharma (Cambodge) provides sales and marketing, logistics and distribution, product licensing and importation services of pharmaceutical, consumer health and nutrition products for and on behalf of reputable multinational clients. In business since 2001, the company has become the 2nd largest distributor in Cambodia.
Zuellig Pharma is one of the largest healthcare services groups in Asia with the purpose of making healthcare more accessible, by providing world-class distribution, digital and commercial services to support the growing healthcare needs in this region. The company was started almost a hundred years ago and has grown to become a US$13 billion business covering 13 markets with over 10,000 employees. Its people serve over 350,000 medical facilities and work with over 1,000 clients, including the top 20 pharmaceutical companies in the world.
Exclusive sell-side advisor in a bilateral discussion: CIGP preformed in-depth financial analysis and valuation of the target company to negotiate an optimal transaction structure on behalf of the shareholders. CIGP worked closely with international law firm Allen & Overy as well as leading local law firm Bun & Associates to finalise the transaction.
Industry experience and local presence: CIGP was able to leverage its experience in the healthcare sector and its presence in Asia to successfully close the transaction. CIGP’s ability to bridge the gap between Asia and the world was key in helping to meet the shareholders’ objectives and preferred strategies.